Back to results
US 2024/0197708 A1Published application
Treatment of prodromal huntington disease
AssigneePrilenia Neurotherapeutics Ltd.
InventorsMichael HAYDEN, Michal GEVA
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods treating prodromal HD in a subject, wherein the subject has at least 36 CAG repeats in the huntingtin (Htt) gene, wherein the method comprises administering a composition comprising pridopidine or a pharmaceutically acceptable salt thereof.
Claims15
A method of treating prodromal Huntington Disease (HD) in a subject who has at least 36 CAG repeats in the huntingtin (Htt) gene, wherein said method comprises administering a composition comprising pridopidine or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.